SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-17-047117
Filing Date
2017-07-27
Accepted
2017-07-26 19:02:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G a17-18375_1sc13g.htm SC 13G 350230
2 GRAPHIC g183751bgi001.gif GRAPHIC 1589
  Complete submission text file 0001104659-17-047117.txt   354006
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13G

Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Subject) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90051 | Film No.: 17984047
SIC: 2834 Pharmaceutical Preparations